LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

MicroRNA Protects Normal Brain from Trauma and Stress

By LabMedica International staff writers
Posted on 14 Jun 2017
Print article
A microRNA has been identified that helps prevent the normal brain from becoming susceptible to the type of seizures induced by trauma or stress in individuals with epilepsy.

MicroRNAs (miRNAs) are a small noncoding family of 19- to 25-nucleotide RNAs that regulate gene expression by targeting messenger RNAs (mRNAs) in a sequence specific manner, inducing translational repression or mRNA degradation, depending on the degree of complementarity between miRNAs and their targets. Many miRNAs are conserved in sequence between distantly related organisms, suggesting that these molecules participate in essential processes. In fact, miRNAs have been shown to be involved in the regulation of gene expression during development, cell proliferation, apoptosis, glucose metabolism, stress resistance, and cancer.

Epilepsy may have genetic or pharmacological origins or may develop following injury. However, it remains unclear how the normal brain escapes susceptibility to seizures.

Investigators at the Hebrew University of Jerusalem (Israel) hypothesized that rapidly inducible microRNAs could mediate such protection. To test this theory, they combined genetic engineering of mouse lines, RNA sequencing, electric recording of brain activity, and learning tests. Specifically, they engineered dTg-211 mice to overproduce a doxycycline-suppressible form of the microRNA miR-211 in their forebrains.

Results published in the June 5, 2017, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences revealed that the genetically engineered mice reacted to doxycycline exposure - which lowered levels of miR-211 - by spontaneous electrocorticography-documented nonconvulsive seizures, accompanied by forebrain accumulation of the convulsive seizures mediating microRNA, miR-134. RNA sequencing of the doxycycline-treated dTg-211 mice showed overrepresentation of synaptic activity, Ca2+ transmembrane transport, TGFBR2 (transforming growth factor, beta receptor II) signaling, and cholinergic synapse pathways.

"Dynamic changes in the amount of miR-211 in the forebrains of these mice shifted the threshold for spontaneous and pharmacologically induced seizures, alongside changes in the cholinergic pathway genes," said senior author Dr. Hermona Soreq, professor of molecular neuroscience at the Hebrew University of Jerusalem. "It is important to discover how only some people's brains present a susceptibility to seizures, while others do not, even when subjected to these same stressors. In searching for the physiological mechanisms that allow some people's brains to avoid epilepsy, we found that increased levels of micro-RNA 211 could have a protective effect."

Related Links:
Hebrew University of Jerusalem

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more